Treatment of Impetigo
For impetigo, the first-line treatment is topical mupirocin 2% ointment applied three times daily for 5-7 days for limited lesions, while oral antibiotics such as dicloxacillin or cephalexin are recommended for extensive disease. 1
First-Line Treatment: Topical Antibiotics
- Mupirocin 2% ointment is FDA-approved for topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes, applied three times daily for 5-7 days 2, 1
- Retapamulin 1% ointment is an effective alternative, applied twice daily for 5 days in patients aged 9 months or older 3, 1
- Topical antibiotics have shown better cure rates than placebo (risk ratio 2.24) in clinical studies 4
- Topical therapy is preferred for limited lesions due to fewer systemic side effects compared to oral antibiotics 5
Second-Line Treatment: Oral Antibiotics
Oral antibiotics should be used in the following scenarios:
- Extensive disease with multiple lesions 1, 6
- When topical therapy is impractical 1
- Failure of topical treatment 1
- Presence of systemic symptoms 6
Recommended oral antibiotics:
For Methicillin-Susceptible S. aureus (MSSA):
For Methicillin-Resistant S. aureus (MRSA):
Special Considerations
Community-Acquired MRSA (CA-MRSA)
- Consider empiric therapy for CA-MRSA in the following situations:
Treatment Duration and Follow-up
- Complete the full course of prescribed antibiotics even if symptoms improve quickly 1
- Topical treatment should be used for 5-7 days 6
- Oral antibiotics should be used for 5-10 days 6
- Re-evaluate if no improvement after 48-72 hours of therapy 6
Common Pitfalls and Caveats
- Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 6, 5
- Oral penicillin V is seldom effective compared to antistaphylococcal penicillins, amoxicillin/clavulanate, cephalosporins, and macrolides 7
- Topical disinfectants are inferior to antibiotics and should not be used 4, 7
- Resistance rates are increasing for commonly used antibiotics, particularly erythromycin 5, 4
- Mupirocin has been shown to be slightly superior to oral erythromycin in multiple studies (risk ratio 1.07) 4